Enveric Biosciences (ENVB) Net Equity Issued and Repurchased (2013 - 2026)
Enveric Biosciences (ENVB) posted Net Equity Issued and Repurchased of $4.25 million for Q2 2026, compared with -$129,403 a year earlier and up 227.7% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Enveric Biosciences was $6.01 million, up 41.5% year-over-year; for FY2025, it was $4.7 million, up 75.5% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 57.3% (FY2020 to FY2025).
- In prior years, Enveric Biosciences' Net Equity Issued and Repurchased was $2.68 million in FY2024, $17.22 million in FY2022 (-20.3%) and $21.61 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 4.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 453,774.00 |
| Jun 30, 2025 | -129,403.00 |
| Mar 31, 2025 | 4.37 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2022 | -1.00 |
| Sep 30, 2022 | 7.82 Mn |
| Mar 31, 2022 | 9.40 Mn |
| Mar 31, 2021 | 21.61 Mn |
| Dec 31, 2020 | 260,500.00 |
| Sep 30, 2020 | -1.50 Mn |
| Jun 30, 2020 | 1.73 Mn |
| Dec 31, 2019 | 169.00 |
| Jun 30, 2019 | 655,830.00 |
| Mar 31, 2019 | 1.47 Mn |
| Dec 31, 2018 | 19,334.00 |
| Sep 30, 2018 | 5.68 Mn |
| Jun 30, 2018 | 9,249.00 |
| Mar 31, 2018 | 619,032.00 |
API Access
Enveric Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();